Yield10 Bioscience to Announce First Quarter 2022 Financial Results and Host a Conference Call on Wednesday, May 11, 2022
Yield10 Bioscience, Inc. (Nasdaq:YTEN) will report its Q1 2022 financial results on May 11, 2022. Following the earnings announcement, management will host a conference call at 4:30 p.m. ET to discuss financial highlights and provide a business update. Interested parties can access the live call by phone or via a webcast. A replay will be available shortly after the call, lasting until May 25, 2022. Yield10 focuses on developing improved Camelina varieties using its 'Trait Factory' platform for agricultural and food industry applications.
- Scheduled conference call to discuss Q1 2022 financial results and corporate updates.
- None.
WOBURN, Mass., May 03, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its first quarter 2022 financial results and provide a corporate update on Wednesday, May 11, 2022.
Management will host a conference call on Wednesday, May 11, 2022 at 4:30 p.m. ET to review financial results, share corporate highlights, and provide an overall business update. Following management’s formal remarks, there will be a question and answer session.
To listen to the conference call, interested parties within the U.S. should call 1-877-709-8150. International callers should call +1-201-689-8354. The call will also be available through a live webcast and will reference a slide deck, both of which may be accessed through the investor relations section of the Company’s website at www.yield10bio.com.
A replay of the call will be available approximately one hour after the end of the call through Wednesday, May 25, 2022. The replay may be accessed via the Company’s website on the investor relations event page, or by dialing 877-660-6853 (toll-free) or +1-201-612-7415 (international). The audio replay passcode is 13728757.
About Yield10 Bioscience
Yield10 Bioscience, Inc. is an agricultural bioscience company that is using its differentiated trait gene discovery platform, the “Trait Factory”, to develop improved Camelina varieties to produce proprietary seed products, and to discover high value genetic traits for the agriculture and food industries. Our goals are to efficiently establish a high value seed products business based on developing superior varieties of Camelina to produce feedstock oils, nutritional oils, and PHA bioplastics, and to license our yield traits to major seed companies for commercialization in major row crops, including corn, soybean and canola. Yield10 is headquartered in Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon, Canada.
For more information about the company, please visit www.yield10bio.com, or follow the Company on Twitter, Facebook and LinkedIn.
(YTEN-G)
Contacts:
Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com
Investor Relations:
Bret Shapiro, (561) 479-8566, brets@coreir.com
Managing Director, CORE IR
Media Inquiries:
Eric Fischgrund, eric@fischtankpr.com
FischTank PR
FAQ
When will Yield10 Bioscience report its Q1 2022 results?
What time is the Yield10 conference call for Q1 2022 results?
How can I listen to the Yield10 Bioscience earnings call?
Is there a replay available for the Yield10 earnings call?
What is Yield10 Bioscience's focus area?
